Advanced Glycation End Product 3 (AGE3) Increases Apoptosis and the Expression of Sclerostin by Stimulating TGF-β Expression and Secretion in Osteocyte-Like MLO-Y4-A2 Cells.

about

Insulin-Stimulated Bone Blood Flow and Bone Biomechanical Properties Are Compromised in Obese, Type 2 Diabetic OLETF Rats TGF-Beta Signaling in Bone with Chronic Kidney Disease

P2860

Q57153235-0FF39049-11C8-4663-9FDF-1F21363810CA Q58789309-54B52906-808C-4C41-AC3B-DEBA259A1F46

P2860

Advanced Glycation End Product 3 (AGE3) Increases Apoptosis and the Expression of Sclerostin by Stimulating TGF-β Expression and Secretion in Osteocyte-Like MLO-Y4-A2 Cells.

Item

http://www.wikidata.org/entity/Q50877793

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Advanced Glycation End Product ...... steocyte-Like MLO-Y4-A2 Cells.

@en

Advanced Glycation End Product 3

@nl

type

Item

label

Advanced Glycation End Product ...... steocyte-Like MLO-Y4-A2 Cells.

@en

Advanced Glycation End Product 3

@nl

prefLabel

Advanced Glycation End Product ...... steocyte-Like MLO-Y4-A2 Cells.

@en

Advanced Glycation End Product 3

@nl

P1476

Advanced Glycation End Product ...... steocyte-Like MLO-Y4-A2 Cells.

@en

P2093

Ayumu Takeno

http://www.w3.org/2001/XMLSchema#string

Ippei Kanazawa

http://www.w3.org/2001/XMLSchema#string

Ken-Ichiro Tanaka

http://www.w3.org/2001/XMLSchema#string

Maki Yokomoto-Umakoshi

http://www.w3.org/2001/XMLSchema#string

Masakazu Notsu

http://www.w3.org/2001/XMLSchema#string

Toru Yamaguchi

http://www.w3.org/2001/XMLSchema#string

Toshitsugu Sugimoto

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

TGFbeta signaling in growth control, cancer, and heritable disorders

Evidence for osteocyte regulation of bone homeostasis through RANKL expression

Load regulates bone formation and Sclerostin expression through a TGFβ-dependent mechanism

Pharmacologic inhibition of the TGF-beta type I receptor kinase has anabolic and anti-catabolic effects on bone.

Tissue-specific calibration of extracellular matrix material properties by transforming growth factor-β and Runx2 in bone is required for hearing

Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling.

TGF-beta regulates the mechanical properties and composition of bone matrix.

High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus.

Advanced glycation end products induce chemokine/cytokine production via activation of p38 pathway and inhibit proliferation and migration of bone marrow mesenchymal stem cells.

P2888

s00223-017-0243-x

P304

402-411

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00223-017-0243-X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28229177

http://www.w3.org/2001/XMLSchema#string

Advanced Glycation End Product 3 (AGE3) Increases Apoptosis and the Expression of Sclerostin by Stimulating TGF-β Expression and Secretion in Osteocyte-Like MLO-Y4-A2 Cells.

about

P2860

P2860

Advanced Glycation End Product 3 (AGE3) Increases Apoptosis and the Expression of Sclerostin by Stimulating TGF-β Expression and Secretion in Osteocyte-Like MLO-Y4-A2 Cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698